Synergistic and Antagonistic Effects of Phenylalanine and Various Antibiotics on the Growth of Pathogenic Bacteria
- 20 Downloads
Broad-spectrum antibiotics have been widely used in the treatment of many systemic and local infections in humans and animals. Herein, we aimed to determine the synergistic and antagonistic effects of phenylalanine with antibiotics cefoxitin, amoxicillin, vancomycin, lincomycin, and bacitracin against 14 pathogenic bacteria. The effect of antibiotics, either alone or in combination with this biomolecular liquid, was tested using the disk diffusion method against different bacteria. The addition of phenylalanine to antibiotic disks directly affected their antimicrobial activity. All the antibiotics used did not show any antimicrobial activity against Staphylococcus haemolyticus when used alone. However, in combination with phenylalanine, each antibiotic inhibited the growth of S. haemolyticus. The use of this biomolecular liquid together with amoxicillin and vancomycin also increased the antimicrobial activity against Enterococcus durans. The use of phenylalanine in combination with antibiotics also resulted in antagonistic effects on some pathogens. Further, the effects of antibiotics in combination with phenylalanine on different bacterial pathogens were investigated in vitro. Results provide valuable information to further our understanding of the molecular mechanism of action of antibiotics and to improve their efficacy against bacterial pathogens.
KeywordsAntagonistic-synergetic effect Pathogenic bacteria strains Phenylalanine
This study was supported by the Research Fund of Kastamonu University Grant No. KÜBAP-01/2016-40.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Hashemi, S., Nasrollah, A., & Rajabi, M. (2013). Irrational antibiotic prescribing: a local issue or global concern? EXCLI Journal, 12, 384–395.Google Scholar
- 5.Gangoue-Pieboji, J., Koulla-Shiro, S., Ngassam, P., Adiogo, D., & Ndumbe, P. (2006). Antimicrobial activity against gram-negative bacilli from Yaounde Central Hospital, Cameroon. African Health Sciences, 6(4), 232–235.Google Scholar
- 8.Aiyelabola, T. O., Isaac, O., & Olugbenga, A. (2012). Structural and antimicrobial studies of coordination compounds of phenylalanine and glycine. International Journal of Chemistry, 4(20), 49.Google Scholar
- 10.Luzzaro, F., Perilli, M., Amicosante, G., Lombardi, G., Belloni, R., Zollo, A., Bianchi, C., & Toniolo, A. (2001). Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations. International Journal of Antimicrobial Agents, 17(2), 131–135.CrossRefGoogle Scholar
- 13.Cockerill, F. R., Patel, J. B., Alder, J., Bradford, P. A., Dudley, M. N., & Eliopoulos, G. M. (2013). Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. Clinical and Laboratory Standards Institue, 33(1), 56238–55866.Google Scholar
- 14.Ferro, B. E., Srivastava, S., Deshpande, D., Pasipanodya, J. G., van Soolingen, D., Mouton, J. W., van Ingen, J., & Gumbo, T. (2016). Failure of the amikacin, cefoxitin, and clarithromycin combination regimen for pulmonary Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy, 60(10), 6374–6376.CrossRefGoogle Scholar
- 15.Broekema, N. M., Van, T. T., Monson, T. A., Marshall, S. A., & Warshauer, D. M. (2009). Comparison of cefoxitin and oxacillin disk diffusion methods for detection of mecA-mediated resistance in Staphylococcus aureus in a large-scale study. Journal of Clinical Microbiology, 47(1), 217–219.CrossRefGoogle Scholar
- 20.Davis, J. S., Sud, A., O'Sullivan, M. V. N., Robinson, J. O., Ferguson, P. E., Foo, H., van Hal, S. J., Ralph, A. P., Howden, B. P., Binks, P. M., Kirby, A., & Tong, S. Y. C. (2016). Combination of vancomycin and β-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial. Clinical Infectious Diseases, 62(2), 173–180.CrossRefGoogle Scholar
- 29.Matos, R., Pinto, V. V., Ruivo, M., & Lopes, M. F. (2009). Study on the dissemination of the bcr ABDR cluster in Enterococcus spp. reveals that the BcrAB transporter is sufficient to confer high-level bacitracin resistance. International Journal of Antimicrobial Agents, 34(2), 142–147.CrossRefGoogle Scholar